Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

1 toradh

  1. SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product|medicament
    lambda inteirféaróin pheigealáitithe Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    peginterferon lambda | pegylated interferon lambda | peginterferon lambda-1a
    en
    Sainmhíniú well-characterised, late-stage, first-in-class, type III interferon (IFN) that stimulates immune responses that are critical for the development of host protection during viral infections Tagairt "American Pharmaceutical Review. 'Eiger Announces Positive Results of COVID-19 Trial' (22.10.2020). Tuesday, October 20, 2020"